MWM
GILD icon

Meadowbrook Wealth Management’s Gilead Sciences GILD Stock Holding History

Meadowbrook Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,575
Closed -$439K – 71
2025
Q4 		$439K Buy
+3,575
New +$434K 0.5% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Meadowbrook Wealth Management's GILD Position: Q1 2026 in Review

Meadowbrook Wealth Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,575 shares — an estimated $439K sold.

Meadowbrook Wealth Management first reported a position in GILD in Q4 2025 and held it in 1 quarter. The position peaked at $439K in Q4 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Meadowbrook Wealth Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Meadowbrook Wealth Management sold 3,575 Gilead Sciences shares in Q1 2026, an estimated $439K.
  • Meadowbrook Wealth Management first reported a position in Gilead Sciences in Q4 2025 and held it in 1 quarter.
  • Meadowbrook Wealth Management's Gilead Sciences position peaked at $439K in Q4 2025.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Meadowbrook Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.